Author:
Yoshimura Koichi,Aoki Hiroki,Ikeda Yasuhiro,Fujii Kozo,Akiyama Norio,Furutani Akira,Hoshii Yoshinobu,Tanaka Nobuyuki,Ricci Romeo,Ishihara Tokuhiro,Esato Kensuke,Hamano Kimikazu,Matsuzaki Masunori
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference44 articles.
1. Curci, J.A., Lee, J.K. & Thompson, R.W. Pathogenesis of Abdominal Aortic Aneurysm. in Current Therapy in Vascular Surgery (eds. Ernst, C.B. & Stanley, J.C.) 199–206 (Elsevier, Philadelphia, 2001).
2. Upchurch, G.R., Jr. Gene therapy to treat aortic aneurysms: right goal, wrong strategy. Circulation 112, 939–940 (2005).
3. Pyo, R. et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest. 105, 1641–1649 (2000).
4. Longo, G.M. et al. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J. Clin. Invest. 110, 625–632 (2002).
5. Allaire, E., Forough, R., Clowes, M., Starcher, B. & Clowes, A.W. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J. Clin. Invest. 102, 1413–1420 (1998).
Cited by
385 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献